Drug intelligence / Profile preview

karaya gum + acacia + tragacanth

Development stage
Discontinued
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Parenteral
01

Overview

Karaya gum + acacia + tragacanth is a legacy combination **allergenic extract** composed of three plant-derived gum allergens: karaya gum, acacia gum arabic, and tragacanth. It was used as a therapeutic allergen immunotherapy product for patients with documented sensitization to these vegetable gum allergens, with the intent of hyposensitization through repeated parenteral exposure to the relevant allergenic materials. Mechanistically, it does not act through a single molecular target; rather, as an allergen extract immunotherapy, it is intended to modulate pathologic allergen-specific immune responses and reduce clinical reactivity to the included gum allergens over time. Available context suggests a multi-dose injectable biologic/allergenic extract product with an inactive FDA NDC listing, and no clearly identifiable contemporary sponsor, implying a compounded, historical, or discontinued marketed allergenic extract rather than an active modern development program.

Other names
karaya gum + acacia + tragacanthallergenic extract karaya gum + acacia + tragacanthvegetable gum allergenic extract

Beyond the preview

Go deeper on karaya gum + acacia + tragacanth.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on karaya gum + acacia + tragacanth.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call